Novel and de novo glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: Implications for geneticcounseling

Citation
F. Rouan et al., Novel and de novo glycine substitution mutations in the type VII collagen gene (COL7A1) in dystrophic epidermolysis bullosa: Implications for geneticcounseling, J INVES DER, 111(6), 1998, pp. 1210-1213
Citations number
21
Categorie Soggetti
Dermatology,"da verificare
Journal title
JOURNAL OF INVESTIGATIVE DERMATOLOGY
ISSN journal
0022202X → ACNP
Volume
111
Issue
6
Year of publication
1998
Pages
1210 - 1213
Database
ISI
SICI code
0022-202X(199812)111:6<1210:NADNGS>2.0.ZU;2-5
Abstract
The dystrophic forms of epidermolysis bullosa (DEB) are due to mutations in the type VII collagen gene (COL7A1). In dominant DEB, a characteristic gen etic lesion is a glycine substitution mutation within the collagenous domai n of the protein. In this study, we have examined the molecular basis of si x new families in which the proband has clinical features and/or ultrastruc tural findings consistent with DEB. The results revealed a glycine substitu tion mutation in all six families, four of which are novel and previously u npublished. In three families with clinically unaffected parents, de novo m utations G2043R and G2040V were found. These results emphasize the predomin ance of glycine substitution mutations in dominant DEB, and indicate that i n some cases the phenotype is due to de novo dominant mutations.